Pipeline

working towards a new first-in-class IND

 

GABAeron is working to deliver a new first-in-class IND candidate to replace or restore neurons injured or lost in the brains of patients suffering from neurodegenerative and neurodevelopmental disorders.

Pipeline Targeting CNS Therapeutics

for Neurodegenerative Disorders

Careers at GABAeron

We are looking for colleagues who are team players, always learning, dedicated to conducting rigorous science, and passionate about improving the lives of patients with neurodegenerative and neurodevelopmental disorders. GABAeron has positions open for those looking to join a focused organization with opportunities to guide early lab discoveries towards meaningful disease-modifying therapeutics.